{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:35:13Z","timestamp":1720679713399},"reference-count":37,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jgyn.2013.11.006","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T08:00:26Z","timestamp":1390032026000},"page":"114-122","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacologie du misoprostol (donn\u00e9es pharmacocin\u00e9tiques, tol\u00e9rance et effets t\u00e9ratog\u00e8nes)"],"prefix":"10.1016","volume":"43","author":[{"given":"J.","family":"Aubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bejan-Angoulvant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-P.","family":"Jonville-Bera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2013.11.006_bib0005","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-5347(01)66315-8","article-title":"The rationale for prostaglandin E1\u00a0in erectile failure: a survey of worldwide experience","volume":"155","author":"Porst","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.AOG.0000124783.38974.53","article-title":"Oral, rectal, and vaginal pharmacokinetics of misoprostol","volume":"103","author":"Khan","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0029-7844(03)00174-1","article-title":"Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor","volume":"101","author":"Khan","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0029-7844(98)00436-0","article-title":"Comparison between oral and vaginal administration of misoprostol on uterine contractility","volume":"93","author":"Danielsson","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/humrep\/dep108","article-title":"Pharmacokinetics of repeated doses of misoprostol","volume":"24","author":"Tang","year":"2009","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0055","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/humrep\/dem098","article-title":"Pharmacokinetic profiles up to 12h after administration of vaginal, sublingual and slow-release oral misoprostol","volume":"22","author":"Aronsson","year":"2007","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0060","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/der303","article-title":"A randomized comparison of pharmacokinetics of a single vaginal dose of dry misoprostol or misoprostol moistened with normal saline or with acetic acid","volume":"26","author":"Lee","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0065","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/16.11.2283","article-title":"Incompelet miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medicale evacuation","volume":"16","author":"Pang","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(06)69522-6","article-title":"Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial","volume":"368","author":"Derman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0075","first-page":"321","article-title":"Misoprostol a synthetic prostaglandin E1\u00a0analogue","volume":"67","author":"O\u2019Keefe","year":"1985","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0080","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1007\/BF01309407","article-title":"Overview of clinical safety with misoprostol","volume":"30","author":"Herting","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000295923","article-title":"Acute coronary artery vasospasme associated with misoprostol for termination of pregnancy","volume":"27","author":"Ilia","year":"2010","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/jmf.10.2.141.145-8","article-title":"Rupture of an unscarred uterus with misoprostol induction: case report and review of literature","volume":"10","author":"Khabbaz","year":"2001","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0095","first-page":"371","article-title":"Rupture ut\u00e9rine sur ut\u00e9rus sain au cours d\u2019une interruption m\u00e9dicale de grossesse du 2e trimestre par misoprostol\u00a0: \u00e0 propos d\u2019un cas trait\u00e9 de mani\u00e8re conservatrice","volume":"31","author":"Letourneur","year":"2002","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0100","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMoa051620","article-title":"Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion","volume":"353","author":"Fischer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0105","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.4049\/jimmunol.180.12.8222","article-title":"Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii","volume":"180","author":"Aronoff","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0110","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMc1001014","article-title":"Fatal Clostridium sordellii infections after medical abortions","volume":"363","author":"Meites","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.AOG.0000287291.19230.ba","article-title":"Toxic Shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion","volume":"110","author":"Cohen","year":"2007","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.contraception.2010.11.006","article-title":"Prevention of infection after induced abortion: release date October 2010: SFP guideline 2010","volume":"83","author":"Achilles","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0140-6736(91)90046-R","article-title":"Misoprostol and congenital malformations","volume":"338","author":"Fonseca","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","article-title":"Congenital abnormalities in Brazilian children associated with misoprostol use in first trimester of pregnancy","volume":"351","author":"Gonzales","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1096-8628(20001211)95:4<297::AID-AJMG1>3.0.CO;2-K","article-title":"Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis","volume":"95","author":"Coelho","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0140","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.reprotox.2006.03.015","article-title":"Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis","volume":"22","author":"Da Silva dal Pizzol","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0890-6238(98)00072-0","article-title":"Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study","volume":"13","author":"Sch\u00fcler","year":"1999","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pediatrneurol.2010.05.026","article-title":"Moebius syndrome and holoprosencephaly following exposure to misoprostol","volume":"43","author":"Pirmez","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0155","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1345\/aph.1K550","article-title":"M\u00f6bius syndrome in a neonate after mifepristone and misoprostol elective abortion failure","volume":"42","author":"Bos-Thompson","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0160","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(95)91540-0","article-title":"M\u00f6bius syndrome after misoprostol: a possible teratogenic mechanism","volume":"346","author":"Shepard","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0029-7844(99)00472-X","article-title":"Misoprostol's effects on uterine arterial blood flow and fetal heart rate in early pregnancy","volume":"95","author":"Yip","year":"2000","journal-title":"Obtest Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/bdra.10144","article-title":"M\u00f6bius sequence in children exposed in utero to misoprostol: neuropathological study of three cases","volume":"67","author":"Marques-Dias","year":"2003","journal-title":"Birth Def Res (Part A)"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0175","first-page":"233","article-title":"Pregnancy outcome after first-trimester misoprostol exposure: a French collaborative study","volume":"19","author":"Messager","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00228-004-0889-y","article-title":"Reproductive results associated with misoprostol and other substances utilized for interruption of pregnancy","volume":"61","author":"Da Silva dal Pizzol","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgyn.2013.11.006_bib0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.reprotox.2012.11.009","article-title":"Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study","volume":"36","author":"Vauzelle","year":"2013","journal-title":"Reprod Toxicol"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513003542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513003542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T03:51:28Z","timestamp":1538884288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231513003542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0368231513003542"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.11.006","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologie du misoprostol (donn\u00e9es pharmacocin\u00e9tiques, tol\u00e9rance et effets t\u00e9ratog\u00e8nes)","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}